Related Experiment Video
Updated: Aug 21, 2026

In Vivo Forward Genetic Screen to Identify Novel Neuroprotective Genes in Drosophila melanogaster
Published on: July 11, 2019
A reverse genetic screen in Drosophila using a deletion-inducing mutagen
Knud Nairz1, Peder Zipperlen, Charles Dearolf
1Zoologisches Institut, Universität Zürich, Winterthurerstrasse 190, Zurich CH-8057, Switzerland. nairz@zool.unizh.ch
Abstract:
We report the use of the cross-linking drug hexamethylphosphoramide (HMPA), which introduces small deletions, as a mutagen suitable for reverse genetics in the model organism Drosophila melanogaster. A compatible mutation-detection method based on resolution of PCR fragment-length polymorphisms on standard DNA sequencers is implemented. As the spectrum of HMPA-induced mutations is similar in a variety of organisms, it should be possible to transfer this mutagenesis and detection procedure to other model systems.
Insights
Hexamethylphosphoramide (HMPA) is a new mutagen for Drosophila reverse genetics, causing small deletions. A PCR-based method detects these mutations, with potential for other model organisms.
Area of Science:
- Molecular Biology
- Genetics
- Developmental Biology
Background:
- Reverse genetics requires efficient mutagenesis and mutation detection methods.
- Model organisms like Drosophila melanogaster are crucial for understanding fundamental biological processes.
Purpose of the Study:
- To introduce hexamethylphosphoramide (HMPA) as a novel mutagen for reverse genetics in Drosophila melanogaster.
- To develop a compatible mutation detection method for HMPA-induced mutations.
- To assess the potential transferability of this approach to other model systems.
Main Methods:
- Utilizing hexamethylphosphoramide (HMPA) as a cross-linking mutagen to induce small deletions.
- Implementing a mutation detection strategy based on polymerase chain reaction (PCR) fragment-length polymorphism analysis.
- Employing standard DNA sequencing technology for polymorphism resolution.
Main Results:
- Hexamethylphosphoramide (HMPA) is demonstrated as a suitable mutagen for Drosophila reverse genetics.
- A reliable PCR-based method for detecting HMPA-induced mutations was successfully implemented.
- The spectrum of HMPA-induced mutations shows similarity across different organisms.
Conclusions:
- Hexamethylphosphoramide (HMPA) offers a valuable tool for reverse genetics in Drosophila.
- The developed mutation detection method is effective and compatible with standard DNA sequencers.
- This mutagenesis and detection protocol is potentially transferable to diverse model organisms, broadening its applicability in genetic research.
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
In-vitro Mutagenesis

